Xarelto 20mg (Rivaroxaban)

Xarelto 20 mg (Rivaroxaban)

Brand Name: Xarelto
Active Ingredient: Rivaroxaban
Strength: 20 mg
Therapeutic Class: Oral Anticoagulant, Direct Factor Xa Inhibitor
Dosage Form: Film-coated tablet
Prescription Status: Prescription-only medication

Overview

Xarelto 20 mg contains Rivaroxaban, which is a direct oral anticoagulant (DOAC) that selectively blocks Factor Xa, an important enzyme involved in the coagulation chain. Through blocking Factor Xa, Rivaroxaban prevents the creation of thrombin as well as the formation of later blood clots.

The drug Xarelto can be used to lower the chance of having a stroke or systemic embolism for patients with non-valvular atrial fibrillation and to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). The drug is highly regarded for its anticoagulant effects that are predictable, as well as its fixed dose and the fact that there is no requirement for routine monitoring.

Composition

• Each Xarelto tablet contains:
  • Rivaroxaban – 20 mg

Indications

Xarelto 20 mg is indicated for:

• The prevention of strokes and systemic embolism in patients suffering from non-valvular atrial fibrillation.
• Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE).
• Prevention of recurrent DVT and PE after initial treatment.
• The prevention of venous thromboembolism (VTE) for patients who undergo a knee or hip replacement operation (dose can differ).

Mechanism of Action

Rivaroxaban is a selective inhibitor that reversibly blocks the factor Xa, which plays a key role in the change of prothrombin into a thrombin-like substance in the coagulation chain. Through blocking Factor Xa, this drug reduces the generation of thrombin and clots as well as the formation of thrombi.

Dosage and Administration

Typical Adult Dosage:

• For Stroke Prevention in Atrial Fibrillation:
  • 20 mg daily, along with a dinner food.
  • A dose adjustment is often required in patients suffering from kidney impairment.
• For Treatment of DVT and PE:
  • Initial dose: 15 mg, twice a day for the first 21 days.
  • Then 20 mg is taken once every day thereafter.
• For Prevention of DVT after Surgery:
  • Dose may vary, but is typically 10 mg taken once a day.

Administration Tips:

• Eat with food to increase absorption.
• Take tablets whole, but don’t crush or chew.
• Follow the dosing plan strictly.

Precautions and Warnings

• Bleeding Risk: A major risk for anticoagulants. Watch for indications of bleeding.
• Renal Impairment: Be cautious and make dosage changes in the case of moderate or extreme kidney impairment.
• Hepatic Impairment: Not recommended for patients suffering from serious liver problems that can be linked to coagulopathy.
• Surgery or Invasive Procedures: Stop using it before undergoing an operation to decrease the chance of bleeding in accordance with the recommendations of your doctor.
• Pregnancy and Lactation: Only use if the benefits are greater than the risks.
• Concomitant Medications: Be cautious with any other medication that increases the risk of bleeding (e.g., NSAIDs, antiplatelets).

Side Effects

Common side effects:

• Bleeding (nosebleeds, gum bleeding, bruising)
• Gastrointestinal discomfort
• Anemia
• Elevated liver enzymes (rare)

Serious side effects:

• Major bleeding (gastrointestinal, intracranial)
• Hypersensitivity reactions
• Thrombocytopenia (rare)

Get medical attention immediately in the event of extreme bleeding, unusual bruising, that is unusual or symptoms of stroke.

Contraindications

• Active pathological bleeding
• Hypersensitivity to rivaroxaban or any components
• Hepatic impairment severe with coagulopathy
• Prosthetic heart valves (safety not established)
• Pregnancy (unless clearly needed)

Drug Interactions

• CYP3A4 and P-gp inhibitors (e.g., ketoconazole, ritonavir) increase rivaroxaban levels, increasing bleeding risk.
• CYP3A4 and P-gp inducers (e.g., rifampin, carbamazepine) may reduce effectiveness.
• Concurrent use with antiplatelets, NSAIDs, or other anticoagulants increases bleeding risk.
• Be sure to inform your doctor regarding any medications you take.

Storage

• Maintain the room temperatures (15°C to 30°C).
• Place tablets in the original container to keep them dry.
• Make sure that the area is safe for young children.

Patient Counseling

• Use the medicine exactly as it is prescribed. Do not take a break between doses.
• Consume with food for better absorption.
• Be on the lookout for signs of bleeding. Report it immediately.
• Inform your healthcare provider regarding Xarelto treatment prior to surgeries or dental treatments.
• Do not engage in activities that carry an increased danger of injury.
• Don’t take any prescription medications or supplements unless you consult with your physician.

Summary

Xarelto 20 mg (Rivaroxaban) is a powerful oral anticoagulant that can help stop blood clots and treat them by blocking the activity of Factor Xa. It is a convenient choice for pre-determined doses and does not require regular coagulation monitors, which makes it an ideal choice for patients who are at risk of developing thromboembolic issues. Adherence and monitoring for the prevention of bleeding are essential for the benefits of treatment and to ensure safety.